These agents have not demonstrated benefit in adenocarcinoma, and evidence for their use in squamous cell carcinoma is limited.57–59 Suppression of VEGF may be effective if the treatment is limited to patients with C-shaped and X-shaped microvessels, particularly in squamous cell carcinoma. Here, VEGFA is linked to squamous cell carcinoma.